Phillip Garfin
Academic Appointments
- Clinical Instructor, Pediatrics - Hematology & Oncology
- Postdoctoral Medical fellow, Pediatrics
Key Documents
Contact Information
-
Clinical Offices
Pediatric Hematology-Oncology 725 Welch Rd MC 5798 Palo Alto, CA 94034 Tel Work (650) 497-8953 Fax (650) 497-8959Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Pediatric Stem Cell Transplantation
- Pediatric Oncology
- Pediatric Hematology
- General Pediatrics
Honors and Awards
- Member, Stanford Society of Physician Scholare (2010 -present)
- Paul and Yuanbi Fellow of Pediatrics, Department of Pediatrics (10/01/2009-9/30/2010)
- MD Scholar, California Institute of Regenerative Medicine (10/01/2010-present)
Professional Education
| Fellowship: | Stanford Hospital and Clinics CA (2012) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (2010) |
| Medical Education: | Univ of Chicago - Pritzker School of Medicine IL (2006) |
| Doctor of Philosophy: | University of Chicago, Genetics, Cell Biology (2004) |
| Doctor of Medicine: | University of Chicago (2006) |
Stanford Advisors
| Julien Sage: | Postdoctoral Research Mentor |
| Arun Rangaswami: | Postdoctoral Faculty Sponsor |
Lab Affiliations
- Julien Sage, Sage Lab (8/2/2010 )
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Currently, I am involved research in a number of fields:
BASIC:
1) the role of the retinoblastoma family of tumor suppressor proteins in the regulation of thymic cellularity and its downstream effect on the immune system
2) immune reconstitution following therapy
3) enhancing immune response to cancer antigens
TRANSLATIONAL:
1) Development of primary retinoblastoma samples as a model system for the study of pediatric cancers and of cell (pluri)potency and differentiation status
CLINICAL (all at various stages of progress):
1) Transplantation for Hodkgin Disease
2) Late effects of transplantation
Publications
- Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression. J Exp Med. 2013
- Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development. Development. 2009; (12): 2081-9
- Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. Hypertension. 1997; (5): 1047-53
Help